-+ 0.00%
-+ 0.00%
-+ 0.00%

Third Rock Ventures V disposes of Rapport Therapeutics shares worth $17.2 million

PUBT·04/21/2026 23:36:51
Listen to the news
Third Rock Ventures V disposes of Rapport Therapeutics shares worth $17.2 million
  • Third Rock Ventures V sold 426,005 shares of Rapport Therapeutics common stock on April 17.
  • Sale priced at weighted average USD 40.32 per share.
  • Third Rock Ventures V held 6,709,228 shares following transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-167636), on April 21, 2026, and is solely responsible for the information contained therein.